
Clinical and epidemiological characteristics of hepatitis C virusinfected people who inject drugs: a Greek descriptive analysis
Author(s) -
Hariklia Kranidioti,
Christina Chatzievagelinou,
Άδωνις Πρωτοπαπάς,
Μargarita Papatheodoridi,
Κonstantinos Ζisimopoulos,
Eftychia Evangelidou,
Pinelopi Antonakaki,
John Vlachogiannakos,
Christos Triantos,
Ioannis Elefsiniotis,
John Goulis,
Maria Mela,
Olga Anagnostou,
Christos Τsoulas,
Melanie Deutsch,
George V. Papatheodoridis,
Spilios Manolakopoulos
Publication year - 2018
Publication title -
annals of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.886
H-Index - 33
eISSN - 1792-7463
pISSN - 1108-7471
DOI - 10.20524/aog.2018.0293
Subject(s) - medicine , cirrhosis , hepatitis c , liver disease , coinfection , hepatitis c virus , epidemiology , diabetes mellitus , gastroenterology , human immunodeficiency virus (hiv) , immunology , virus , endocrinology
It is estimated that 17,000 people who inject drugs (PWID) in Greece have hepatitis C virus (HCV) viremia. The aim of our study was to explore the characteristics of the HCV-infected, direct acting antiviral (DAA)-naïve PWID.